Omega Pharma is a dynamic organization specialized in developing, manufacturing and sale of medical devices, food supplements and medical cosmetics as on the OTC pharmaceutical market as in wide distribution on the mass-market. It is part of the multinational group Omega Pharma which is headquartered in Belgium and present in 40 countries.
High specialization, professionalism and superior customer service have enabled a dynamic development of the company and it has been included among the major players on the market.
From the very beginning, Omega Pharma has been a marketing-driven company with a strong focus on customer’s needs, requirements and resulting satisfaction. It holds many patents and applies unique solutions to high-efficiency products in product lines.
The company now has its own Development Center of Excellence. In terms of research and its application we interact with renowned centers in the Czech Republic and across Europe.
The products registered at the Industrial Property Rights in Czech Republic come from our own research laboratory. We participate in research and development of the products with guaranteed support of the state organizations and our priorities include not only development but also responsible clinical testing of each product prior to launching it into the market.
Contact
OMEGA PHARMA A.S.
Drážní 253/7
Brno 62700
+420 800 400 113
The latest pharma news from Central and Eastern Europe (CEE), including a new report on the disparities between the region’s healthcare systems and those of Western Europe; why US companies…
Roman Grunt, CEO of Quinta Analytica, gives us an overview of the activities of how the Czech firm has managed to attract customers across the country and beyond by positioning…
PharmaBoardroom’s latest report: Healthcare & Life Sciences Review: Czech Republic is available for download now. Home to a USD 3.38 billion pharma market, one of Central and Eastern Europe’s…
Key stakeholders within the Czech medtech industry highlight how medical devices can improve efficiency and quality of care across the country’s healthcare landscape, why greater levels of collaboration are of…
Roman Samiec, general manager of Thuasne Czech Republic, introduces the company as a key competitor in the medical devices field, with their niche products addressing the unmet medical need in…
Miroslav Palát, president of CzechMed, the medical device association in the Czech Republic, and Jiří Pavlíček, who combines the responsibility of Chairman of the association and CEO of the medtech…
Pavla Nevolová, country head of EastHORN in the Czech Republic, shares the historical roots of the now multinational Czech CRO. Nevolová also shares her insights into the recent evolution of…
The Czech Republic boasts a solid clinical research infrastructure and a supportive regulatory environment, meaning that it stands out as one of Central and Eastern Europe’s top destinations for clinical…
In 1996 Jiří Žák, chairman & current CEO of FARMAK, borrowed half a billion Czech crowns to take over a state-owned producer of vitamins for which he had started working…
As one of the few pharma companies in the Czech Republic to offer products across the whole healthcare spectrum, including prescription drugs, generics, over-the-counter (OTC) treatments, and food supplements, the…
Roman Dusil, GM of Pierre Fabre Laboratories in the Czech Republic and Slovakia, shares how the Czech affiliate is ahead of Pierre Fabre’s global transformation of the convergence between the dermo-cosmetic…
Pharma industry stakeholders are generally quick to suggest that the Czech Republic is one of the most over-regulated markets in Europe, with new or innovative therapies facing significant delays before…
See our Cookie Privacy Policy Here
